Title : Overall cardiovascular profile of sildenafil citrate.

Pub. Date : 1999 Mar 4

PMID : 10078541






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sildenafil, a selective inhibitor of phosphodiesterase type 5 (PDE5), is the first in a new class of orally effective treatments for erectile dysfunction. Sildenafil Citrate phosphodiesterase 5A Homo sapiens
2 Sildenafil, a selective inhibitor of phosphodiesterase type 5 (PDE5), is the first in a new class of orally effective treatments for erectile dysfunction. Sildenafil Citrate phosphodiesterase 5A Homo sapiens
3 Sildenafil facilitates the erectile process during sexual stimulation by inhibiting PDE5 and thus blocking the breakdown of cGMP. Sildenafil Citrate phosphodiesterase 5A Homo sapiens